Elanco Animal Health Incorporated Disposal Group, Including Discontinued Operation, Assets, Current
Elanco Animal Health Incorporated (ELAN) had Disposal Group, Including Discontinued Operation, Assets, Current of $627.00 million as of 2024-06-30, per its 10-Q filed 2024-08-08.
Discontinued › Balance Sheet › Assets › Assets, Current
us-gaap:AssetsOfDisposalGroupIncludingDiscontinuedOperationCurrent · last filed 2024-08-08
- 2024-06-30: Disposal Group, Including Discontinued Operation, Assets, Current $627.00M.
- 2024-03-31: Disposal Group, Including Discontinued Operation, Assets, Current $651.00M.
- 2023-12-31: Disposal Group, Including Discontinued Operation, Assets, Current $0.00.
| Period end | Disposal Group, Including Discontinued Operation, Assets, Current |
|---|---|
| 2024-06-30 | $627.00M 10-Q · filed 2024-08-08 |
| 2024-03-31 | $651.00M 10-Q · filed 2024-05-08 |
| 2023-12-31 | $0.00 10-Q · filed 2024-08-08 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| MADRIGAL PHARMACEUTICALS, INC. (MDGL) | United States | $11.859B | -38.17 |
| BIOMARIN PHARMACEUTICAL INC (BMRN) | United States | $11.879B | 151.80 |
| Axsome Therapeutics, Inc. (AXSM) | United States | $10.274B | -66.82 |
| CORCEPT THERAPEUTICS INC (CORT) | United States | $12.804B | 169.10 |
| BridgeBio Pharma, Inc. (BBIO) | United States | $12.947B | -20.72 |
| ARROWHEAD PHARMACEUTICALS, INC. (ARWR) | United States | $9.331B | -42.28 |
| Summit Therapeutics Inc. (SMMT) | United States | $13.071B | -13.21 |
| CYTOKINETICS INC (CYTK) | United States | $9.130B | -11.86 |
| Protagonist Therapeutics, Inc (PTGX) | United States | $8.883B | 95.52 |
| TG THERAPEUTICS, INC. (TGTX) | United States | $8.805B | 19.05 |